Recently, on metastatic samples from the autopsy of a patient with prostate cancer, the lethal metastatic clone had genomic alterations, including a TP53 mutation, which enabled to track its origin back to a minority sub-clone with the same TP53 mutation in the primary tumor [11]. Here, TP53 is linked to prostate carcinoma.